Complement System Components and Inhibitors in Cutaneous Squamous Cell Carcinoma

被引：0
|
作者：
Riihila, P. [1 ,2 ]
Ala-aho, R. [1 ,2 ]
Kallajoki, M. [3 ]
Grenman, R. [4 ]
Meri, S. [5 ]
Peltonen, J. [6 ]
Kahari, V. M. [1 ,2 ]
机构：
[1] Univ Turku, Dept Dermatol & Venereol, Turku, Finland
[2] Univ Turku, Med Res Lab, Turku, Finland
[3] Turku Univ, Cent Hosp, Dept Pathol, Turku, Finland
[4] Turku Univ, Cent Hosp, Dept Otorhinolaryngol Head & Neck Surg, Turku, Finland
[5] Univ Helsinki, Haartman Inst, FIN-00014 Helsinki, Finland
[6] Univ Turku, Dept Anat & Cell Biol, SF-20500 Turku, Finland
来源：
JOURNAL OF INVESTIGATIVE DERMATOLOGY | 2009年 / 129卷
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：S73 / S73
页数：1
相关论文
共 50 条
  • [41] Cutaneous horn due to cutaneous squamous cell carcinoma
    Zhang, Li-wen
    Chen, Tao
    MEDICAL JOURNAL OF AUSTRALIA, 2022, 217 (11) : 586 - 586
  • [42] Complement Factor D Is a Novel Biomarker and Putative Therapeutic Target in Cutaneous Squamous Cell Carcinoma
    Rahmati Nezhad, Pegah
    Riihilae, Pilvi
    Knuutila, Jaakko S.
    Viiklepp, Kristina
    Peltonen, Sirkku
    Kallajoki, Markku
    Meri, Seppo
    Nissinen, Liisa
    Kahari, Veli-Matti
    CANCERS, 2022, 14 (02)
  • [43] C3 and complement factor B regulate growth of cutaneous squamous cell carcinoma
    Riihila, P.
    Nissinen, L.
    Farshchian, M.
    Kallajoki, M.
    Kivisaari, A.
    Meri, S.
    Pihlajaniemi, T.
    Heljasvaara, R.
    Peltonen, S.
    Kahari, V.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2016, 136 (09) : S245 - S245
  • [44] Complement C3a promotes proliferation, migration and stemness in cutaneous squamous cell carcinoma
    Fan, Zhuo
    Qin, Jingjing
    Wang, Dandan
    Geng, Songmei
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2019, 23 (05) : 3097 - 3107
  • [45] Incomplete Data in Cutaneous Squamous Cell Carcinoma Staging System Analysis
    Jambusaria-Pahlajani, Anokhi
    Karia, Pritesh S.
    Schmults, Chrysalyne D.
    JAMA DERMATOLOGY, 2018, 154 (12) : 1488 - 1488
  • [46] PD-1 inhibitors for cutaneous squamous cell carcinoma: A meta-analysis
    Aboul-Fettouh, Nader
    Chen, Leon
    Ma, Junsheng
    Patel, Jigar
    Silapunt, Sirunya
    Migden, Michael
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2022, 63 (01) : 36 - 42
  • [47] Immune checkpoint inhibitors in cutaneous squamous cell carcinoma: A systematic review of clinical trials
    Anwar, Muhammad Yasir
    Aiman, Wajeeha
    Ali, Muhammad Ashar
    Dhanesar, Gurneel
    Zafar, Maha
    Omar, Zainab
    Afzal, Fatima
    Guron, Gunwant K.
    Shaaban, Hamid Salim
    Maroules, Michael
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [48] Tumor cell-derived complement components C1r and C1s promote growth of cutaneous squamous cell carcinoma
    Riihila, Pilvi
    Nissinen, Liisa
    Farshchian, Mehdi
    Kallajoki, Markku
    Kivisaari, Atte
    Meri, Seppo
    Grenman, Reidar
    Peltonen, Sirkku
    Peltonen, Juha
    Kahari, Veli-Matti
    CANCER RESEARCH, 2018, 78 (13)
  • [49] Tumour-cell-derived complement components C1r and C1s promote growth of cutaneous squamous cell carcinoma
    Riihila, P.
    Viiklepp, K.
    Nissinen, L.
    Farshchian, M.
    Kallajoki, M.
    Kivisaari, A.
    Meri, S.
    Peltonen, J.
    Peltonen, S.
    Kahari, V. -M.
    BRITISH JOURNAL OF DERMATOLOGY, 2020, 182 (03) : 658 - 670
  • [50] Tumor cell-derived complement components C1r and C1s promote growth of cutaneous squamous cell carcinoma
    Riihila, P.
    Viiklepp, K.
    Nissinen, L.
    Farshchian, M.
    Kallajoki, M.
    Kivisaari, A.
    Meri, S.
    Grenman, R.
    Peltonen, S.
    Peltonen, J.
    Kahari, V.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2017, 137 (10) : S285 - S285
12345